Acrolein exacerbates atherosclerosis in apoE-null mice

被引:0
|
作者
Bhatnagar, A [1 ]
West, M [1 ]
Bolanowski, D [1 ]
Liu, SQ [1 ]
Prabhu, SD [1 ]
Srivastava, S [1 ]
机构
[1] Univ Louisville, Louisville, KY 40202 USA
来源
FASEB JOURNAL | 2002年 / 16卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A173 / A173
页数:1
相关论文
共 50 条
  • [31] RAGE Signaling in Macrophages Contributes to Atherosclerosis in ApoE Null Mice
    Shen, Xiaoping
    Rosario, Rosa
    Lu, Yan
    Yen, Shi Fang
    Schmidt, Ann Marie
    CIRCULATION, 2009, 120 (18) : S1119 - S1119
  • [32] Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice
    Palombo, Francesca
    Shen, Hao
    Benguigui, Lea Esther S.
    Kazarian, Sergei G.
    Upmacis, Rita K.
    ANALYST, 2009, 134 (06) : 1107 - 1118
  • [33] O-Glycosylation Regulates Ubiquitination and Degradation of the Anti-Inflammatory Protein A20 to Accelerate Atherosclerosis in Diabetic ApoE-Null Mice
    Shrikhande, Gautam V.
    Scali, Salvatore T.
    da Silva, Cleide G.
    Damrauer, Scott M.
    Csizmadia, Eva
    Putheti, Prabhakar
    Matthey, Michaela
    Arjoon, Roy
    Patel, Rakesh
    Siracuse, Jeffrey J.
    Maccariello, Elizabeth R.
    Andersen, Nicholas D.
    Monahan, Thomas
    Peterson, Clayton
    Essayagh, Sanah
    Studer, Peter
    Guedes, Renata Padilha
    Kocher, Olivier
    Usheva, Anny
    Veves, Aristidis
    Kaczmarek, Elzbieta
    Ferran, Christiane
    PLOS ONE, 2010, 5 (12):
  • [34] Hypoxia-inducible factor 2alpha activation disrupts cholesterol metabolism homeostasis of liver and accelerates atherosclerosis in apoE-null mice
    Qu, Aijuan
    Jiang, Changtao
    Li, Fei
    Tanaka, Naoki
    Gao, Bin
    Shah, Yatrik M.
    Gonzalez, Frank J.
    HEPATOLOGY, 2013, 58 : 336A - 336A
  • [35] Contribution of inducible nitric oxide synthase to protein tyrosine nitration and biopterin oxidation in ApoE-null mice
    Upmacis, Rita K.
    Crabtree, Mark J.
    Deeb, Ruba S.
    Shen, Hao
    Lane, Paul B.
    Maeda, Nobuyo
    Hajjar, David P.
    Gross, Steven S.
    FASEB JOURNAL, 2007, 21 (06): : A1146 - A1146
  • [36] Intermedin ameliorates atherosclerosis in apoE null mice by modifying lipid profiles
    Zhang, Xin
    Gu, Lunda
    Chen, Xiaoping
    Wang, Si
    Deng, Xiaoming
    Liu, Kai
    Lv, Zhengbing
    Yang, Rui
    Sen He
    Peng, Yong
    Huang, Dejia
    Jiang, Wei
    Wu, Kai
    PEPTIDES, 2012, 37 (02) : 189 - 193
  • [37] RVX-208 DECREASES PROGRESSION OF ATHEROSCLEROSIS IN APOE NULL MICE
    Wong, Norman C.
    Jahagirdar, Ravi
    Azhar, Salam
    Zhang, Haiyan
    Gordon, Allan
    Chiacchia, Fabrizio S.
    Wagner, Gregory S.
    Johansson, Jan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1437 - E1437
  • [38] Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase
    Conde-Knape, K
    Bensadoun, A
    Sobel, JH
    Cohn, JS
    Shachter, NS
    JOURNAL OF LIPID RESEARCH, 2002, 43 (12) : 2136 - 2145
  • [39] Lipoic acid prevents atherosclerosis lesion development in ApoE null mice
    Ma, Xiaoyan
    Padmalayam, Indira
    Cahoon, Sientay
    Chakrabarti, Ranjan
    Pillarisetti, Sivaram
    Saxena, Uday
    DIABETES, 2006, 55 : A497 - A497
  • [40] The Proatherogenic Effect of Chronic Nitric Oxide Synthesis Inhibition in ApoE-Null Mice Is Dependent on the Presence of PPARα
    Vechoropoulos, Michal
    Ish-Shalom, Maya
    Shaklai, Sigal
    Sack, Jessica
    Stern, Naftali
    Tordjman, Karen M.
    PPAR RESEARCH, 2014, 2014